Explanation of the Anticancer Mechanism and Clinical Chemotherapy for Hybrid Liposomes
Explanation of the Anticancer Mechanism and Clinical Chemotherapy for Hybrid Liposomes
批准号:
14350439
负责人:
UEOKA Ryuichi
金额:
$9.22万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2004
中文摘要
杂化脂质体可以通过在缓冲溶液中简单地超声处理囊泡和胶束分子的混合物来制备。这些脂质体的物理性质,如大小、膜流动性、相变温度和疏水性可以通过改变组成来控制。在我们的研究过程中,杂种脂质体在体外无需药物的情况下对肿瘤生长具有非常高的抑制作用。杂交脂质体对体外正常细胞和体内正常大鼠均无毒性,无副作用。本文报道了由二myristoyl磷脂酰胆碱(DMPC)和聚氧乙烯烷基醚(C_<12>(EO)n;N =10-25),在体外、体内及临床化疗中均对肿瘤细胞生长有抑制作用。本研究值得注意的方面总结如下:(a)得到了DMPC与C_<12>(EO)_n组成的杂化脂质体结构均匀稳定。(b)杂化脂质体对多种肿瘤细胞的体外生长具有高度抑制作用。(c)首次证实杂化脂质体通过激活死亡结构域和某些半胱天冬酶诱导细胞凋亡。(d)接种肿瘤细胞的小鼠经杂交脂质体处理后,存活时间明显延长,无任何副作用。(e)在临床应用中,对于淋巴瘤等肿瘤患者,经静脉注射杂交脂质体无需药物即可延长生存期,局部给予杂交脂质体可显著减少实体瘤。
英文摘要
Hybrid liposomes can be prepared by simply ultrasonicating a mixture of vesicular and micellar molecules in a buffer solution. The physical properties of these liposomes, such as size, membrane fluidity phase transition temperature, and hydrophobicity can be controlled by changing the composition. In the course of our study, remarkably high inhibitory effects of hybrid liposomes on tumor growth in vitro without drugs have been obtained. No toxicity of the hybrid liposomes was observed in normal cells in vitro and in normal rats in vivo without any side effect.In this study, we report on the uniform and stable hybrid liposomes composed of dimyristoylphosphatidylcholine (DMPC) and polyoxyethylenealkyl ether (C_<12>(EO)n; n=10-25) having inhibitory effects on the growth of tumor cells in vitro, in vivo and clinical chemotherapy.Asummary of the noteworthy aspects of this study is as follows : (a) the uniform and stable structure of hybrid liposomes composed of DMPC and C_<12>(EO)_n was obtained. (b) Highly inhibitory effects of hybrid liposomes were obtained on the growth of many kinds of tumor cells in vitro. (c) Induction of apoptosis by hybrid liposomes through activation of death domains and some kind of caspases was verified for the first time. (d) Significantly prolonged survival was obtained in mice inoculated tumor cells after the treatment with hybrid liposomes without any side effect. (e) In clinical application, the prolonged survival was attained in patient with lymphoma and other tumors after the intravenous injection of hybrid liposomes without drugs and the remarkable reduction of solid tumor was obtained after the local administration of hybrid liposomes.
期刊论文(68)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Hybrid Liposomes as a Drug Carrier for the Oral Administration of Insulin in Diabetic Rats
混合脂质体作为糖尿病大鼠口服胰岛素的药物载体
DOI:
--
发表时间:
2004
期刊:
YAKUGAKU ZASSHI vol.124 No.4
影响因子:
--
作者:
[K.Nakashima, M.Miyagi, K.Goto, Y.Matsumoto, R.Ueoka]
通讯作者:
R.Ueoka
Hideaki nagami: "Induction of Apoptosis by Hybrid Liposomes without Antitumor Drugs toward Human Breast Tumor Cells"Journal of Chemical Engineering of Japan. 36・9. 1127-1129 (2003)
Hideaki nagami:“不使用抗肿瘤药物的混合脂质体对人乳腺肿瘤细胞的凋亡诱导”日本化学工程学报36・9(2003)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kentaro Nakashima: "Enzymatic and Hyperglycemia Stability of Chemically Modified Insulins with Hydrophobic Acyl Groups"Bioorganic & Medicinal Chemistry Letters. 14・4. 481-483 (2003)
中岛健太郎:“疏水酰基化学修饰胰岛素的酶促稳定性和高血糖稳定性”《生物有机与药物化学快报》14・4(2003 年)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
蛋白質 核酸 酵素 増刊号 科学と生物学の接点がつくるNEWバイオテクノロジー「アポトーシス誘導ハイブリッドリポソームのがん治療効果」
蛋白质核酸酶特刊科学与生物学交叉创造的新生物技术“诱导细胞凋亡的混合脂质体的癌症治疗作用”
DOI:
--
发表时间:
2003
期刊:
影响因子:
--
作者:
[Yoshio Suzuki, Hirokazu Komatsu, Takafumi Ikeda, Naohiko Saito, Sawa Araki, Daniel Citterio, Hideaki Hisamoto, Yoshiichiro Kitamura, Takeshi Kubota. Jun Nakagawa, Kotaro Oka, Koji Suzuki, 松本 陽子]
通讯作者:
松本 陽子
生体内の高分子 機能材料開発と医療への新展開「リポソームによる癌治療」
体内高分子功能材料开发及医学新进展“利用脂质体治疗癌症”
DOI:
--
发表时间:
2003
期刊:
影响因子:
--
作者:
[上岡 龍一]
通讯作者:
上岡 龍一
共 40 条
Medical technological study of nano chemotherapy using hybrid liposomes for the refractory disease
-
批准号:25289299
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.15万
-
财政年份:2013
-
负责人:UEOKA Ryuichi
-
依托单位:
Basic and applied study on AIDS-therapy using hybrid liposomes
-
批准号:24656509
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.58万
-
财政年份:2012
-
负责人:UEOKA Ryuichi
-
依托单位:
Development of Nanotherapy System for Intractable Disease with Hybrid Liposomes-Cancer therapy with hybrid liposomes-
-
批准号:20360377
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.4万
-
财政年份:2008
-
负责人:UEOKA Ryuichi
-
依托单位:
Chemotherapy with hybrid liposomes and application to drug delivery system with hybrid liposomes
-
批准号:17360403
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$10.48万
-
财政年份:2005
-
负责人:UEOKA Ryuichi
-
依托单位:
Antitum of Mechanism of Hybrid Liposomes and Clinical Application
-
批准号:12555232
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$6.4万
-
财政年份:2000
-
负责人:UEOKA Ryuichi
-
依托单位:
Functional Molecular Assemblies Coupled to Steric Control with High Enantioselectivity
-
批准号:07650968
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.34万
-
财政年份:1995
-
负责人:UEOKA Ryuichi
-
依托单位:
海外基金